Trial Profile
Evaluation of retreatment efficacy and predictors of ledipasvir plus sofosbuvir therapy in patients with Hepatitis-C genotype 1 infection in Japan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Sep 2017 New trial record